PDPN and metastatic malignant neoplasm in the lymph nodes: In the patients without lymph node metastasis, there was no significant difference in DFS or DSS according to PDPN expression, but in those with lymph node metastases, the high PDPN group had significantly poorer DFS and DSS rates than the low PDPN group (Fig. 4).